semaglutide factory india patent loss opens up a $6 billion opportunity for Indian generic drug makers Eris Lifesciences partners with Natco

Understanding their effectiveness, side effects, and overall suitability is essential for making an informed treatment decision in 2026

They are not effective, have little scientific evidence to back up their claims, and are misleading because they do not contain any GLP-1 agonists

Ozempic is a daily injectable drug thats used to treat type 2 diabetes and has been shown to promote weight loss in some cases

Joudren M, Bourhours-Nouet N, Ansellem-Jager J, et al

Table 2 represents the comorbidities observed in patients prescribed oral semaglutide at baseline

2 Take home message Retatrutide isnt legally available in the UK in 2026